Free Webinar Series
Dr Philip Gribbon, Assistant Head of Department at Frauenhofer IME – ScreeningPort, describes recent efforts to identify small molecule therapeutics for the treatment of SARS-CoV-2 infection and COVID-19 disease. In this context, he presents approaches to screen libraries of drugs and clinical candidates for potentially therapeutic repurposing.
Dr Philip Gribbon and Dr Andrea Beccari discuss the EXSCALATE4CoV (E4C) project, an international research consortium financed by the European Union charged with accelerating drug repurposing to target SARS-Cov2 and building a network of experts, resources and tools to better address potential future pandemics.
.
.